Benzinga | Nov 5, 2021 09:32AM EDT

Arena Pharmaceuticals Q3 EPS $(3.21) Misses $(2.53) Estimate

Arena Pharmaceuticals (NASDAQ:ARNA) reported quarterly losses of $(3.21) per share which missed the analyst consensus estimate of $(2.53) by 26.88 percent. This is a 89.94 percent decrease over losses of $(1.69) per share from the same period last year.